single invest

AAA Chemistry

AAA Chemistry has created a new technology which provides antibody-drug conjugates with complete chemo- and site-selectivity in more than 95% yields and excellent stability. Their protein-drug bioconjugation technology relies on a patented irreversible conjugation process.

AAA Chemistry has been a part of the Accelerace accelerator program, that help startup companies accelerate and scale up their business model and finetune their companies. AAA Chemistry is one of more than 500 companies that Accelerace already have accelerated.

Related startups